These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25463536)

  • 1. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
    Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
    J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
    Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
    Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
    Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
    Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
    Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
    Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.
    Desai MM; Gong B; Chan T; Davey RA; Soong L; Kolokoltsov AA; Sun J
    Gastroenterology; 2011 Aug; 141(2):674-85, 685.e1-6. PubMed ID: 21683701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
    Dansako H; Ikeda M; Kato N
    FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.
    Berger KL; Sarrazin C; Nelson DR; Scherer J; Sha N; Marquis M; Côté-Martin A; Vinisko R; Stern JO; Mensa FJ; Kukolj G
    PLoS One; 2016; 11(8):e0160668. PubMed ID: 27494410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
    Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
    J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
    Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
    Horner SM; Park HS; Gale M
    J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
    Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
    J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy.
    Brenndörfer ED; Brass A; Karthe J; Ahlén G; Bode JG; Sällberg M
    J Immunol; 2014 Feb; 192(4):1671-80. PubMed ID: 24442435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors.
    Dultz G; Shimakami T; Schneider M; Murai K; Yamane D; Marion A; Zeitler TM; Stross C; Grimm C; Richter RM; Bäumer K; Yi M; Biondi RM; Zeuzem S; Tampé R; Antes I; Lange CM; Welsch C
    J Biol Chem; 2020 Oct; 295(40):13862-13874. PubMed ID: 32747444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.
    Hiscott J; Lacoste J; Lin R
    Biochem Pharmacol; 2006 Nov; 72(11):1477-84. PubMed ID: 16876765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
    Morikawa K; Lange CM; Gouttenoire J; Meylan E; Brass V; Penin F; Moradpour D
    J Viral Hepat; 2011 May; 18(5):305-15. PubMed ID: 21470343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.
    Li XD; Sun L; Seth RB; Pineda G; Chen ZJ
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17717-22. PubMed ID: 16301520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
    Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
    Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.